Recent Finacing
Recent Raise
Insighta develops FRAGMA, a cfDNA fragment-pattern methylation platform for non-invasive, epigenetics-based early cancer detection, conducting clinical trials in China (initially liver, expanding to lung) with Tencent AI collaboration.
